Yipeng Du

1.1k total citations
37 papers, 805 citations indexed

About

Yipeng Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Yipeng Du has authored 37 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Yipeng Du's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Peptidase Inhibition and Analysis (4 papers). Yipeng Du is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Peptidase Inhibition and Analysis (4 papers). Yipeng Du collaborates with scholars based in China, United States and Netherlands. Yipeng Du's co-authors include Taotao Wei, Xiaolong He, Fuquan Yang, Tanxi Cai, Hao Hu, Wei Peng, Tingting Li, Peng Xue, Pingsheng Liu and Bei He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Functional Materials and The Science of The Total Environment.

In The Last Decade

Yipeng Du

35 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yipeng Du China 16 433 109 103 100 92 37 805
Fei Mo China 15 345 0.8× 25 0.2× 50 0.5× 100 1.0× 61 0.7× 33 1.0k
Rupak Pathak United States 20 426 1.0× 38 0.3× 121 1.2× 180 1.8× 13 0.1× 65 914
Yuan Song China 17 178 0.4× 148 1.4× 66 0.6× 78 0.8× 10 0.1× 57 896
Chunlei Li China 19 284 0.7× 51 0.5× 84 0.8× 93 0.9× 9 0.1× 64 922
Zhonglan Su China 18 388 0.9× 196 1.8× 100 1.0× 110 1.1× 9 0.1× 38 855
Yujuan Ouyang China 8 175 0.4× 57 0.5× 45 0.4× 67 0.7× 10 0.1× 10 483
Ji‐Long Hao China 17 453 1.0× 57 0.5× 49 0.5× 31 0.3× 14 0.2× 43 1.0k
Brie K. Fuqua United States 14 201 0.5× 81 0.7× 66 0.6× 74 0.7× 17 0.2× 18 797

Countries citing papers authored by Yipeng Du

Since Specialization
Citations

This map shows the geographic impact of Yipeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yipeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yipeng Du more than expected).

Fields of papers citing papers by Yipeng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yipeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yipeng Du. The network helps show where Yipeng Du may publish in the future.

Co-authorship network of co-authors of Yipeng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yipeng Du. A scholar is included among the top collaborators of Yipeng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yipeng Du. Yipeng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Du, Yipeng, et al.. (2024). Nanoplastics causes heart aging/myocardial cell senescence through the Ca2+/mtDNA/cGAS-STING signaling cascade. Journal of Nanobiotechnology. 22(1). 96–96. 36 indexed citations
3.
Zhou, Haobin, Haoyu Song, Yuanqing Li, et al.. (2024). LncRNA CARMN inhibits abdominal aortic aneurysm formation and vascular smooth muscle cell phenotypic transformation by interacting with SRF. Cellular and Molecular Life Sciences. 81(1). 175–175. 14 indexed citations
4.
Du, Yipeng, et al.. (2023). Successful management of camrelizumab-induced immune-checkpoint-inhibitors-related myocarditis. Journal of Oncology Pharmacy Practice. 30(3). 597–604. 2 indexed citations
5.
Zhou, Min, et al.. (2023). Zearalenone induces the senescence of cardiovascular cells in vitro and in vivo. Environmental Science and Pollution Research. 30(19). 56037–56053. 5 indexed citations
6.
Du, Yipeng, et al.. (2023). The role of metabolism in cellular quiescence. Journal of Cell Science. 136(16). 10 indexed citations
8.
He, Zhiyu, Xiaojun Zeng, Peiying Liu, et al.. (2021). LncRNA Chaer Prevents Cardiomyocyte Apoptosis From Acute Myocardial Infarction Through AMPK Activation. Frontiers in Pharmacology. 12. 649398–649398. 12 indexed citations
9.
Du, Yipeng, Xiaoting Li, Wenying Yan, et al.. (2021). Deciphering the in vivo Dynamic Proteomics of Mesenchymal Stem Cells in Critical Limb Ischemia. Frontiers in Cell and Developmental Biology. 9. 682476–682476. 5 indexed citations
10.
Zhang, Eric, Chaoshan Han, Chengming Fan, et al.. (2021). Visualization and Identification of Bioorthogonally Labeled Exosome Proteins Following Systemic Administration in Mice. Frontiers in Cell and Developmental Biology. 9. 657456–657456. 11 indexed citations
11.
Du, Yipeng, et al.. (2019). Genetically Encoded FapR-NLuc as a Biosensor to Determine Malonyl-CoA in Situ at Subcellular Scales. Bioconjugate Chemistry. 30(3). 826–832. 12 indexed citations
12.
Du, Yipeng, Hao Hu, Jifeng Wang, et al.. (2018). SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob mice. EBioMedicine. 36. 347–357. 53 indexed citations
13.
Du, Yipeng, et al.. (2018). Tissue distribution, subcellular localization, and enzymatic activity analysis of human SIRT5 isoforms. Biochemical and Biophysical Research Communications. 503(2). 763–769. 22 indexed citations
14.
Liu, Shuo, Jie Chen, Qian Zhao, et al.. (2018). Cardiovascular benefits of short-term indoor air filtration intervention in elderly living in Beijing: An extended analysis of BIAPSY study. Environmental Research. 167. 632–638. 33 indexed citations
15.
Shen, Ning, Yipeng Du, John R. Erb‐Downward, et al.. (2018). Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease. International Journal of COPD. Volume 13. 2289–2299. 16 indexed citations
16.
Shen, Ning, Yipeng Du, Beibei Liu, et al.. (2016). Fetuin-B (FETUB): a Plasma Biomarker Candidate Related to the Severity of Lung Function in COPD. Scientific Reports. 6(1). 30045–30045. 27 indexed citations
17.
Du, Yipeng, Wei Wang, Wei Yang, & Bei He. (2014). Interleukin-32, not reduced by salmeterol/fluticasone propionate in smokers with chronic obstructive pulmonary disease. Chinese Medical Journal. 127(9). 1613–1618. 5 indexed citations
18.
Du, Yipeng & Taotao Wei. (2014). Inputs and outputs of insulin receptor. Protein & Cell. 5(3). 203–213. 36 indexed citations
19.
Du, Yipeng, Tanxi Cai, Tingting Li, et al.. (2014). Lysine Malonylation Is Elevated in Type 2 Diabetic Mouse Models and Enriched in Metabolic Associated Proteins. Molecular & Cellular Proteomics. 14(1). 227–236. 105 indexed citations
20.
Wang, Xiaohua, et al.. (2013). Trapping volumetric measurement by multidetector CT in chronic obstructive pulmonary disease: Effect of CT threshold. Medical Physics. 40(8). 82103–82103. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026